Approvals
After US approval, Amylyx faces regulatory hurdle in Europe for ALS treatment
Relyvrio is once again at the heart of another debate over ALS trial endpoints; this time in Europe.
FDA accepts GSK’s sBLA for Jemperli to treat endometrial cancer
US FDA expands approval for Merck’s PREVYMIS (letermovir)
EC grants marketing authorisation for Fennec’s Pedmarqsi
FDA approves INJECTAFER for iron deficiency in heart failure adult patients
USPTO issues notice of allowance for Enveric’s EVM301 series
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
